These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29982583)
1. Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial. Sorgdrager FJH; Werumeus Buning J; Bos EH; Van Beek AP; Kema IP J Clin Endocrinol Metab; 2018 Sep; 103(9):3411-3419. PubMed ID: 29982583 [TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial. Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Sluiter WJ; Tucha O; Wolffenbuttel BH; van Beek AP Neuroendocrinology; 2016; 103(6):771-8. PubMed ID: 26646751 [TBL] [Abstract][Full Text] [Related]
3. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial. Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800 [TBL] [Abstract][Full Text] [Related]
4. Tryptophan and Kynurenine Levels and Its Association With Sleep, Nonphysical Fatigue, and Depression in Chronic Hemodialysis Patients. Malhotra R; Persic V; Zhang W; Brown J; Tao X; Rosales L; Thijssen S; Finkelstein FO; Unruh ML; Ikizler A; Garimella PS; Ix JH; Kooman J; Levin NW; Handelman GJ; Kotanko P J Ren Nutr; 2017 Jul; 27(4):260-266. PubMed ID: 28366444 [TBL] [Abstract][Full Text] [Related]
5. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway. Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal associations of plasma kynurenines and ratios with fatigue and quality of life in colorectal cancer survivors up to 12 months post-treatment. Holthuijsen DDB; van Roekel EH; Bours MJL; Ueland PM; Breukink SO; Janssen-Heijnen MLG; Keulen ETP; Brezina S; Gigic B; Peoples AR; Ulrich CM; Ulvik A; Weijenberg MP; Eussen SJPM Int J Cancer; 2024 Oct; 155(7):1172-1190. PubMed ID: 38783597 [TBL] [Abstract][Full Text] [Related]
7. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial. Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664 [TBL] [Abstract][Full Text] [Related]
8. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients]. Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722 [TBL] [Abstract][Full Text] [Related]
9. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial. Werumeus Buning J; van Faassen M; Brummelman P; Dullaart RP; van den Berg G; van der Klauw MM; Kerstens MN; Stegeman CA; Muller Kobold AC; Kema IP; Wolffenbuttel BH; van Beek AP J Clin Endocrinol Metab; 2016 Oct; 101(10):3691-3699. PubMed ID: 27490921 [TBL] [Abstract][Full Text] [Related]
10. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Mangge H; Summers KL; Meinitzer A; Zelzer S; Almer G; Prassl R; Schnedl WJ; Reininghaus E; Paulmichl K; Weghuber D; Fuchs D Obesity (Silver Spring); 2014 Jan; 22(1):195-201. PubMed ID: 23625535 [TBL] [Abstract][Full Text] [Related]
11. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599 [TBL] [Abstract][Full Text] [Related]
12. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls. Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713 [TBL] [Abstract][Full Text] [Related]
13. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder. Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866 [TBL] [Abstract][Full Text] [Related]
14. Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement. Zinellu A; Sotgia S; Mangoni AA; Sanna M; Satta AE; Carru C Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):153-9. PubMed ID: 25534866 [TBL] [Abstract][Full Text] [Related]
15. The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation. de Vries LV; Minović I; Franssen CFM; van Faassen M; Sanders JS; Berger SP; Navis G; Kema IP; Bakker SJL Am J Physiol Renal Physiol; 2017 Aug; 313(2):F475-F486. PubMed ID: 28490533 [TBL] [Abstract][Full Text] [Related]
16. The effect of prebiotic supplementation on serum levels of tryptophan and kynurenine in obese women with major depressive disorder: a double-blinded placebo-controlled randomized clinical trial. Khademi F; Tutunchi H; Vaghef-Mehrabani E; Ebrahimi-Mameghani M BMC Res Notes; 2024 Oct; 17(1):316. PubMed ID: 39428497 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial. Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880 [TBL] [Abstract][Full Text] [Related]
18. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency. Quinkler M; Miodini Nilsen R; Zopf K; Ventz M; Øksnes M Eur J Endocrinol; 2015 May; 172(5):619-26. PubMed ID: 25656494 [TBL] [Abstract][Full Text] [Related]
19. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807 [TBL] [Abstract][Full Text] [Related]